[1] Sbaraglia M, Bellan E, Dei Tos AP. The 2020 WHO classification of soft tissue tumours: news and perspectives[J]. Pathologica, 2021, 113(2):70-84.
[2] Frezza AM, Botta L, Trama A, et al. Chordoma: update on disease, epidemiology, biology and medical therapies[J]. Curr Opin Oncol, 2019, 31(2):114-120.
[4] Das P, Soni P, Jones J, et al. Descriptive epidemiology of chordomas in the United States[J]. J Neurooncol, 2020, 148(1):173-178.
[5] Ulici V, Hart J. Chordoma[J]. Arch Pathol Lab Med, 2022, 146(3):386-395.
[6] Kremenevski N, Schlaffer SM, Coras R, et al. Skull base chordomas and chondrosarcomas[J]. Neuroendocrinology, 2020, 110(9-10):836-847.
[7] Baquero-Hoyos MM, Marino JA, Mayorga JL. Nasopharyngeal neuroglial heterotopy - choristoma: case report and review of the literature[J]. World J Otorhinolaryngol Head Neck Surg, 2020, 7(4):318-321.
[8] Khurram SA, Biswas D, Fernando M. A Parapharyngeal soft tissue chordoma presenting with synchronous cervical lymph node metastasis: an unusual presentation[J]. Head Neck Pathol, 2016, 10(3):400-404.
[9] Essammaa E. Chordoma of the oropharynx[J]. J Laryngol Otol, 1959, 73:65-68.
[10] Burge AJ. A case of oropharyngeal chordoma[J]. J Laryngol Otol, 1975, 89:115-119.
[11] Wang YP, Lee KS, Chen YJ, et al. Extraosseous chordoma of the retropharyngeal space[J]. Otolaryngol Head Neck Surg, 2004, 130(3):383-385.
[12] Köyba şioǧlu F, Simşek GG, Onal BU, et al. Oropharyngeal chordoma diagnosed by fine needle aspiration: a case report[J]. Acta Cytol, 2005, 49(2):173-176.
[13] Tian K, Wang L, Ma J, et al. MR imaging grading system for skull base chordoma[J]. AJNR Am J Neuroradiol, 2017, 38(6):1206-1211.
[14] Olson JT, Wenger DE, Rose PS, et al. Chordoma: 18F-FDG PET/CT and MRI imaging features[J]. Skeletal Radiol, 2021, 50(8):1657-1666.
[15] Cheney MD, Chen YL, Lim R, et al.[18F]-Fluoromisonidazole positron emission tomography/computed tomography visualization of tumor hypoxia in patients with chordoma of the mobile and sacrococcygeal spine[J]. Int J Radiat Oncol Biol Phys, 2014, 90(5):1030-1036.
[17] Rekhi B, Michal M, Ergen FB, et al. Poorly differentiated chordoma showing loss of SMARCB1/INI1: clinicopathological and radiological spectrum of nine cases, including uncommon features of a relatively under-recognized entity[J]. Ann Diagn Pathol, 2021, 55:151809.
[18] Dridi M, Boutonnat J, Dumollard JM, et al. Patterns of brachyury expression in chordomas[J]. Ann Diagn Pathol, 2021, 53:151760.
[19] Karele EN, Paze AN. Chordoma: to know means to recognize[J]. Biochim Biophys Acta Rev Cancer, 2022, 1877(5):188796.
[20] Laskar S, Kakoti S, Khanna N, et al. Outcomes of osteosarcoma, chondrosarcoma and chordoma treated with image guided-intensity modulated radiation therapy[J]. Radiother Oncol, 2021, 164:216-222.
[21] Ozair MZ, Shah PP, Mathios D, et al. New prospects for molecular targets for chordomas[J]. Neurosurg Clin N Am, 2020, 31(2):289-300.